|
ZCCHC11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.885800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.278030E-01 |
| Normal-vs-Stage2 |
8.676800E-01 |
| Normal-vs-Stage3 |
7.625800E-01 |
| Normal-vs-Stage4 |
5.859600E-01 |
| Stage1-vs-Stage2 |
5.781400E-01 |
| Stage1-vs-Stage3 |
5.600800E-01 |
| Stage1-vs-Stage4 |
9.610600E-01 |
| Stage2-vs-Stage3 |
9.584600E-01 |
| Stage2-vs-Stage4 |
7.110800E-01 |
| Stage3-vs-Stage4 |
6.918200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.964200E-01 |
| Normal-vs-AfricanAmerican |
6.284600E-01 |
| Normal-vs-Asian |
5.497200E-01 |
| Caucasian-vs-AfricanAmerican |
9.088000E-01 |
| Caucasian-vs-Asian |
8.868600E-01 |
| AfricanAmerican-vs-Asian |
9.172200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.285500E-02 |
| Normal-vs-Female |
4.600100E-02 |
| Male-vs-Female |
1.423940E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.372800E-01 |
| Normal-vs-Extreme_Weight |
5.216200E-02 |
| Normal-vs-Obese |
9.118200E-01 |
| Normal-vs-Extreme_Obese |
8.215800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.743360E-01 |
| Normal_Weight-vs-Obese |
8.874400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.523200E-01 |
| Extreme_Weight-vs-Obese |
1.312770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.311600E-01 |
| Obese-vs-Extreme_Obese |
8.847400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.417900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.850600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.000300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.683360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.806600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.846270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.834320E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.495900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.016300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.848800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.352200E-01 |
| Normal-VS-Type2 PRCC |
1.607560E-01 |
| Normal-VS-KIRP CIMP |
7.763000E-01 |
| Normal-VS-Unclassified PRCC |
7.734000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.227000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.474800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.234000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.386000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.345000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.776600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.202600E-01 |
| Normal-vs-N1 |
3.820600E-01 |
| Normal-vs-N2 |
8.662200E-01 |
| N0-vs-N1 |
9.991500E-02 |
| N0-vs-N2 |
7.361400E-01 |
| N1-vs-N2 |
9.383600E-01 |
|
|
